{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:22:02Z","timestamp":1782768122660,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vph.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:52:12Z","timestamp":1551217932000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Drug-induced hypertension: Know the problem to know how to deal with it"],"prefix":"10.1016","volume":"115","author":[{"given":"Stefano","family":"Masi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Uliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2019.02.002_bb0005","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet."},{"issue":"2018","key":"10.1016\/j.vph.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijcard.2017.03.151","article-title":"Cardiovascular risk and hypertension control in Italy. Data from the 2015 World Hypertension Day","volume":"243","author":"Torlasco","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ackd.2014.10.002","article-title":"Our own worst enemy: pharmacologic mechanisms of hypertension","volume":"22","author":"Kassel","year":"2015","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.vph.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4158\/EP.4.6.387","article-title":"Adrenal insufficiency--an unusual cause of shock in postoperative patients","volume":"4","author":"Sabharwal","year":"1998","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.vph.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570161043476483","article-title":"Glucocorticoids and vascular reactivity","volume":"2","author":"Yang","year":"2004","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/07435809509030436","article-title":"Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo","volume":"21","author":"Kornel","year":"1995","journal-title":"Endocr. Res."},{"key":"10.1016\/j.vph.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/HYPERTENSIONAHA.107.105718","article-title":"Glucocorticoid-related signaling effects in vascular smooth muscle cells","volume":"51","author":"Molnar","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.vph.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.niox.2004.01.008","article-title":"Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene","volume":"10","author":"Wallerath","year":"2004","journal-title":"Nitric Oxide Biol. Chem."},{"key":"10.1016\/j.vph.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.0000258106.74139.25","article-title":"Cardiovascular effects of the cyclooxygenase inhibitors","volume":"49","author":"White","year":"2007","journal-title":"Hypertension."},{"key":"10.1016\/j.vph.2019.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00228-012-1283-9","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study","volume":"68","author":"Fournier","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2015.06.027","article-title":"Drug induced hypertension--an unappreciated cause of secondary hypertension","volume":"763","author":"Grossman","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0065","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0b013e3283310dc9","article-title":"Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis","volume":"27","author":"Chan","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.110.956490","article-title":"Acetaminophen increases blood pressure in patients with coronary artery disease","volume":"122","author":"Sudano","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2019.02.002_bb0075","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/14656566.2013.816286","article-title":"Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients","volume":"14","author":"Gualtierotti","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.vph.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2019.02.002_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","article-title":"Paracetamol: new vistas of an old drug","volume":"12","author":"Bertolini","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.vph.2019.02.002_bb0090","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/jhh.2017.45","article-title":"The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis","volume":"31","author":"Penninkilampi","year":"2017","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0008-6363(03)00468-1","article-title":"The cardiovascular effects of erythropoietin","volume":"59","author":"Smith","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2019.02.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084848","article-title":"Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients","volume":"8","author":"Suttorp","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vph.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1291\/hypres.27.79","article-title":"Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients","volume":"27","author":"Miyashita","year":"2004","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.vph.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2215\/CJN.05040908","article-title":"Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA)","volume":"4","author":"Krapf","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0895-7061(95)96212-3","article-title":"Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case-control study","volume":"8","author":"Narkiewicz","year":"1995","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0125","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/jch.13042","article-title":"Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis","volume":"19","author":"Liu","year":"2017","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1751-7176.2008.06552.x","article-title":"Hypertension in women: part I","volume":"10","author":"Igho Pemu","year":"2008","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.contraception.2013.04.003","article-title":"Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study","volume":"88","author":"Cagnacci","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.vph.2019.02.002_bb0140","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1210\/jcem.84.6.5724","article-title":"Hypertension in women","volume":"84","author":"August","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2003.09.002","article-title":"Progestogen-only pills and high blood pressure: is there an association? A literature review","volume":"69","author":"Hussain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.vph.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2005.10.006","article-title":"Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women","volume":"19","author":"Ichikawa","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MBP.0b013e32830d4b60","article-title":"Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study","volume":"13","author":"de Carvalho","year":"2008","journal-title":"Blood Press. Monit."},{"key":"10.1016\/j.vph.2019.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/01.hjh.0000173394.39197.4e","article-title":"Relationship of alcohol consumption to 7-year blood pressure change in Japanese men","volume":"23","author":"Yoshita","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0165","doi-asserted-by":"crossref","first-page":"g4164","DOI":"10.1136\/bmj.g4164","article-title":"Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data","volume":"349","author":"Holmes","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vph.2019.02.002_bb0170","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1524-6175.2006.05177.x","article-title":"Does consumption of high-caffeine energy drinks affect blood pressure?","volume":"8","author":"Cohen","year":"2006","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.vph.2019.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3945\/ajcn.111.016667","article-title":"The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis","volume":"94","author":"Mesas","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.vph.2019.02.002_bb0180","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11906-014-0468-2","article-title":"Blood pressure in relation to coffee and caffeine consumption","volume":"16","author":"Guessous","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.vph.2019.02.002_bb0185","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archinte.165.15.1686","article-title":"Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis","volume":"165","author":"Salerno","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vph.2019.02.002_bb0190","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2019.02.002_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.gore.2016.06.002","article-title":"Bevacizumab induced hypertension in gynecologic cancer: does it resolve after completion of therapy?","volume":"17","author":"Corr","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.vph.2019.02.002_bb0200","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-09-0058","article-title":"Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment","volume":"15","author":"Maitland","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vph.2019.02.002_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1470-2045(08)70003-2","article-title":"Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Wu","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vph.2019.02.002_bb0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11906-018-0871-1","article-title":"Management of VEGF-targeted therapy-induced hypertension","volume":"20","author":"Caletti","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.vph.2019.02.002_bb0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cjca.2014.02.011","article-title":"Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome","volume":"30","author":"Small","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.vph.2019.02.002_bb0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","article-title":"Hypertension after renal transplantation","volume":"21","author":"Ponticelli","year":"1993","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.vph.2019.02.002_bb0225","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1016\/j.transproceed.2004.01.089","article-title":"Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients","volume":"36","author":"Snanoudj","year":"2004","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.vph.2019.02.002_bb0230","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archinte.1995.00430050022003","article-title":"High blood pressure. A side effect of drugs, poisons, and food","volume":"155","author":"Grossman","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.vph.2019.02.002_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007893.pub2","article-title":"Effect of cyclosporine on blood pressure","author":"Robert","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.vph.2019.02.002_bb0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.vph.2019.02.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2018.06.012","article-title":"Treatment of cyclosporine induced hypertension: results from a long-term observational study using different antihypertensive medications","author":"Marienhagen","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003598.pub2","article-title":"Antihypertensive treatment for kidney transplant recipients","author":"Cross","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.vph.2019.02.002_bb0255","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.1985.196","article-title":"Effect of cyclosporine administration on renal hemodynamics in conscious rats","volume":"28","author":"Murray","year":"1985","journal-title":"Kidney Int."},{"issue":"Suppl. 2","key":"10.1016\/j.vph.2019.02.002_bb0260","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/00005344-199800002-00002","article-title":"Combination of ACE inhibitors and calcium antagonists: a logical approach","volume":"31","author":"Ruschitzka","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0265","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/157016112798829823","article-title":"Hypertension and endothelial dysfunction: therapeutic approach","volume":"10","author":"Ghiadoni","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2019.02.002_bb0270","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.fct.2018.06.054","article-title":"Mechanism of cyclosporine a nephrotoxicity: oxidative stress, autophagy, and signalings","volume":"118","author":"Wu","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.vph.2019.02.002_bb0275","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials","volume":"66","author":"Penninga","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119300345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119300345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T07:07:28Z","timestamp":1554534448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189119300345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":55,"alternative-id":["S1537189119300345"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2019.02.002","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hypertension: Know the problem to know how to deal with it","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}